drugset
drugset / Trial / NCT02791945

N-acetylcysteine Treatment of Alcohol Use Disorder In Veterans With TBI

NCT02791945 ↗

Phase 2 Completed 30 enrolled University of California, San Francisco Institute for Translational Neuroscience · collabNorthern California Institute of Research and Education · collabSan Francisco Veterans Affairs Medical Center · collabUnited States Department of Defense · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

The goal of the project is to improve the care of Veterans with mild traumatic brain injury (mTBI) and unhealthy alcohol use.

Timeline

Start
2016-08
Primary completion
2018-05
Completion
2018-05

Drugs

EvaluationDrugModalityDoseRoute
Subject N-acetylcysteine Small molecule 3200 mg —

Indications

alcohol-related disorders traumatic brain injury